Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Lau

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 12, 2000
The use of ethambutol has lowered the 2-year mortality rate in patients with tuberculous meningitisK K Lau
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 15, 2016
Transition care in Hong KongK K Lau
Hepatology International|August 12, 2009
Hepatitis B reactivation after chemotherapy: two decades of clinical researchGeorge K K Lau
The Medical Journal of Malaysia|August 20, 2005
Treatment of immunosuppressed chronic hepatitis B patientsGeorge K K Lau
Journal of Hepatology|November 23, 2006
Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?George K K Lau
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2010
Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversionGeorge K K Lau
Hepatology International|July 24, 2015
Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases-the controversy arises again?George K K Lau
Clinical Liver Disease|May 2, 2019
How do we handle the anti-HBc positive patient? (in highly endemic settings)George K K Lau
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferonGeorge K K Lau
Gastroenterology|March 26, 2009
A new magic bullet for chronic hepatitis B infection: is this the end of the story?George K K Lau
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 12, 2000
The use of ethambutol has lowered the 2-year mortality rate in patients with tuberculous meningitisK K Lau
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 15, 2016
Transition care in Hong KongK K Lau
Hepatology International|August 12, 2009
Hepatitis B reactivation after chemotherapy: two decades of clinical researchGeorge K K Lau
The Medical Journal of Malaysia|August 20, 2005
Treatment of immunosuppressed chronic hepatitis B patientsGeorge K K Lau
Journal of Hepatology|November 23, 2006
Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?George K K Lau
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2010
Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversionGeorge K K Lau
Hepatology International|July 24, 2015
Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases-the controversy arises again?George K K Lau
Clinical Liver Disease|May 2, 2019
How do we handle the anti-HBc positive patient? (in highly endemic settings)George K K Lau
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferonGeorge K K Lau
Gastroenterology|March 26, 2009
A new magic bullet for chronic hepatitis B infection: is this the end of the story?George K K Lau
Pageof 19